Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 18586992)

1.

Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder.

Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS.

Psychiatr Serv. 2008 Jul;59(7):753-9. doi: 10.1176/appi.ps.59.7.753.

PMID:
18586992
2.

A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis.

Sajatovic M, Davis MS, Cassidy KA, Nestor J, Sams J, Fuentes-Casiano E.

Patient Prefer Adherence. 2015 Jun 8;9:753-8. doi: 10.2147/PPA.S81724. eCollection 2015.

3.

Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.

Levin JB, Tatsuoka C, Cassidy KA, Aebi ME, Sajatovic M.

Compr Psychiatry. 2015 Apr;58:29-36. doi: 10.1016/j.comppsych.2014.11.023. Epub 2014 Dec 27.

PMID:
25617964
4.

Managing bipolar moods without medication: a qualitative investigation.

Cappleman R, Smith I, Lobban F.

J Affect Disord. 2015 Mar 15;174:241-9. doi: 10.1016/j.jad.2014.11.055. Epub 2014 Dec 5.

5.

Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients.

Ezquiaga E, García-López A, de Dios C, Agud JL, Albillo D, Vega-Piris L.

Psychiatr Q. 2014 Dec;85(4):467-77. doi: 10.1007/s11126-014-9303-9.

PMID:
24986371
6.

Monitoring pharmacotherapy response, safety, and tolerability to enhance adherence in bipolar disorder.

Keck PE Jr.

J Clin Psychiatry. 2014 May;75(5):e12. doi: 10.4088/JCP.13010tx4c. Review.

PMID:
24922490
7.

Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.

Arvilommi P, Suominen K, Mantere O, Leppämäki S, Valtonen H, Isometsä E.

J Affect Disord. 2014 Feb;155:110-7. doi: 10.1016/j.jad.2013.10.032. Epub 2013 Oct 28.

PMID:
24262639
8.

Treatment adherence in bipolar I and schizoaffective disorder, bipolar type.

Murru A, Pacchiarotti I, Amann BL, Nivoli AM, Vieta E, Colom F.

J Affect Disord. 2013 Dec;151(3):1003-8. doi: 10.1016/j.jad.2013.08.026. Epub 2013 Sep 3.

PMID:
24099884
9.

Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.

Sylvia LG, Hay A, Ostacher MJ, Miklowitz DJ, Nierenberg AA, Thase ME, Sachs GS, Deckersbach T, Perlis RH.

J Clin Psychopharmacol. 2013 Jun;33(3):343-50. doi: 10.1097/JCP.0b013e3182900c6f.

10.

Prospective risk factors for suicide attempts in a treated sample of patients with borderline personality disorder.

Links PS, Kolla NJ, Guimond T, McMain S.

Can J Psychiatry. 2013 Feb;58(2):99-106.

PMID:
23442897
11.

[Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].

Bouhlel S, M'solly M, Benhawala S, Jones Y, El-Hechmi Z.

Encephale. 2013 Feb;39(1):6-12. doi: 10.1016/j.encep.2012.06.003. Epub 2012 Sep 25. French.

PMID:
23095582
12.

Predictors of prospectively examined suicide attempts among youth with bipolar disorder.

Goldstein TR, Ha W, Axelson DA, Goldstein BI, Liao F, Gill MK, Ryan ND, Yen S, Hunt J, Hower H, Keller M, Strober M, Birmaher B.

Arch Gen Psychiatry. 2012 Nov;69(11):1113-22.

13.

Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.

Badiee J, Riggs PK, Rooney AS, Vaida F, Grant I, Atkinson JH, Moore DJ; Hiv Neurobehavioral Research Program (HNRP) Group.

AIDS Patient Care STDS. 2012 Jul;26(7):388-94. doi: 10.1089/apc.2011.0447. Epub 2012 Jun 11.

14.

Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients.

Murru A, Pacchiarotti I, Nivoli AM, Bonnin CM, Patrizi B, Amann B, Vieta E, Colom F.

Acta Psychiatr Scand. 2012 May;125(5):412-8. doi: 10.1111/j.1600-0447.2012.01837.x. Epub 2012 Feb 9.

PMID:
22321052
15.

Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.

Sajatovic M, Levin J, Tatsuoka C, Micula-Gondek W, Williams TD, Bialko CS, Cassidy KA.

Psychiatr Serv. 2012 Feb 1;63(2):176-8. doi: 10.1176/appi.ps.201100133.

PMID:
22302337
16.

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L.

BMC Psychiatry. 2011 Oct 28;11:171. doi: 10.1186/1471-244X-11-171.

17.

Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.

Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M.

Psychiatr Serv. 2011 Sep;62(9):1032-40. doi: 10.1176/appi.ps.62.9.1032.

PMID:
21885581
18.

Medication therapy: adherence, knowledge and difficulties of elderly people from bipolar disorder.

Cruz LP, Miranda PM, Vedana KG, Miasso AI.

Rev Lat Am Enfermagem. 2011 Jul-Aug;19(4):944-52. English, Portuguese, Spanish.

19.

Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.

Sankaranarayanan J, Collier D, Furasek A, Reardon T, Smith LM, McCartan M, Langnas AN.

Res Social Adm Pharm. 2012 May-Jun;8(3):228-39. doi: 10.1016/j.sapharm.2011.04.001.

PMID:
21856247
20.

The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.

Sajatovic M, Micula-Gondek W, Tatsuoka C, Bialko C.

Gend Med. 2011 Aug;8(4):261-8. doi: 10.1016/j.genm.2011.06.002. Epub 2011 Jul 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk